Rating: 5 out of 5 stars
5/5
Unavailable
Unavailable
Unavailable
Ebook272 pages4 hours
Industry Influence in Federal Regulatory Agencies
Rating: 0 out of 5 stars
()
Currently unavailable
Currently unavailable
About this ebook
Federal regulatory agencies are often assumed to be excessively responsive to and influenced by the corporate interests they are supposed to regulate. On the basis of direct empirical examination, Paul Quirk challenges this assumption as it relates to four United States federal regulatory agencies. Through a series of interviews with high-level officials of the Federal Trade Commission, the Civil Aeronautics Board, the Food and Drug Administration, and the National Highway Traffic Safety Administration, he determines whether and what kinds of incentives exist to adopt policies favorable to industry.
Originally published in 1981.
The Princeton Legacy Library uses the latest print-on-demand technology to again make available previously out-of-print books from the distinguished backlist of Princeton University Press. These editions preserve the original texts of these important books while presenting them in durable paperback and hardcover editions. The goal of the Princeton Legacy Library is to vastly increase access to the rich scholarly heritage found in the thousands of books published by Princeton University Press since its founding in 1905.
Unavailable
Related to Industry Influence in Federal Regulatory Agencies
Titles in the series (6)
Engineers of Happy Land: Technology and Nationalism in a Colony Social Bodies: Science, Reproduction, and Italian Modernity Rating: 5 out of 5 stars5/5The Interpretation of Quantum Mechanics Rating: 3 out of 5 stars3/5Regulating the Social: The Welfare State and Local Politics in Imperial Germany Rating: 0 out of 5 stars0 ratingsColonialism and Revolution in the Middle East: Social and Cultural Origins of Egypt's Urabi Movement Rating: 4 out of 5 stars4/5Gibeon, Where the Sun Stood Still: The Discovery of the Biblical City Rating: 4 out of 5 stars4/5
Related ebooks
Competition, Regulation, and the Public Interest in Nonlife Insurance Rating: 0 out of 5 stars0 ratingsThe Structure and Performance of the Aerospace Industry Rating: 0 out of 5 stars0 ratingsDoes Regulation Kill Jobs? Rating: 0 out of 5 stars0 ratingsThe Politics of Global Regulation Rating: 0 out of 5 stars0 ratingsReforming Asian Labor Systems: Economic Tensions and Worker Dissent Rating: 0 out of 5 stars0 ratingsBureaucratic Opposition: Challenging Abuses at the Workplace Rating: 0 out of 5 stars0 ratingsConcentration and Price-Cost Margins in Manufacturing Industries Rating: 0 out of 5 stars0 ratingsAn Interactive History of the Clean Air Act: Scientific and Policy Perspectives Rating: 0 out of 5 stars0 ratingsCompetition Policy and Price Fixing Rating: 0 out of 5 stars0 ratingsUniversity-Industry Research Interactions: The Technology Policy and Economic Growth Series Rating: 0 out of 5 stars0 ratingsReputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA Rating: 3 out of 5 stars3/5Government Purchasing and Competition Rating: 0 out of 5 stars0 ratingsHealth Services Planning Rating: 0 out of 5 stars0 ratingsA History of a cGMP Medical Event Investigation Rating: 0 out of 5 stars0 ratingsRegulatory Breakdown: The Crisis of Confidence in U.S. Regulation Rating: 0 out of 5 stars0 ratingsAmerican Healthcare & the Consumer Experience: Four Scenarios Rating: 0 out of 5 stars0 ratingsBuilding Biotechnology: Biotechnology Business, Regulations, Patents, Law, Policy and Science Rating: 0 out of 5 stars0 ratingsPrinciples and Practice of Pharmaceutical Medicine Rating: 0 out of 5 stars0 ratingsCollective Bargaining and Productivity: The Longshore Mechanization Agreement Rating: 0 out of 5 stars0 ratingsTo America's Health: A Proposal to Reform the Food and Drug Administration Rating: 0 out of 5 stars0 ratingsRegulation and Public Interests: The Possibility of Good Regulatory Government Rating: 0 out of 5 stars0 ratingsUnhealthy Politics: The Battle over Evidence-Based Medicine Rating: 4 out of 5 stars4/5Antitrust Policy: The Case for Repeal Rating: 0 out of 5 stars0 ratingsLeading Pharmaceutical Innovation: How to Win the Life Science Race Rating: 0 out of 5 stars0 ratingsNatural Monopoly and Its Regulation Rating: 0 out of 5 stars0 ratingsMaking Environmental Policy Rating: 0 out of 5 stars0 ratingsPharmaceutical Toxicology in Practice: A Guide to Non-clinical Development Rating: 0 out of 5 stars0 ratingsMobilizing Restraint: Democracy and Industrial Conflict in Post-Reform South Asia Rating: 0 out of 5 stars0 ratingsScientific Method for Auditing: Applications of Statistical Sampling Theory to Auditing Procedure Rating: 0 out of 5 stars0 ratingsChemicals, Cancer, and Choices: Risk Reduction Through Markets Rating: 0 out of 5 stars0 ratings
American Government For You
Disloyal: A Memoir: The True Story of the Former Personal Attorney to President Donald J. Trump Rating: 4 out of 5 stars4/5Corruptible: Who Gets Power and How It Changes Us Rating: 4 out of 5 stars4/563 Documents the Government Doesn't Want You to Read Rating: 3 out of 5 stars3/5The Room Where It Happened: A White House Memoir Rating: 3 out of 5 stars3/5The Great Reset: And the War for the World Rating: 4 out of 5 stars4/5Dear America: Notes of an Undocumented Citizen Rating: 4 out of 5 stars4/5An Introduction to Legal Reasoning Rating: 0 out of 5 stars0 ratings25 Lies: Exposing Democrats’ Most Dangerous, Seductive, Damnable, Destructive Lies and How to Refute Them Rating: 4 out of 5 stars4/5The U.S. Constitution with The Declaration of Independence and The Articles of Confederation Rating: 5 out of 5 stars5/5Fear: Trump in the White House Rating: 4 out of 5 stars4/5Unwoke: How to Defeat Cultural Marxism in America Rating: 1 out of 5 stars1/5The Lemon Tree: An Arab, a Jew, and the Heart of the Middle East Rating: 4 out of 5 stars4/5The 9/11 Report: The National Commission on Terrorist Attacks Upon the United States Rating: 4 out of 5 stars4/5Why We're Polarized Rating: 4 out of 5 stars4/5Laptop from Hell: Hunter Biden, Big Tech, and the Dirty Secrets the President Tried to Hide Rating: 4 out of 5 stars4/5The Devil's Chessboard: Allen Dulles, the CIA, and the Rise of America's Secret Government Rating: 5 out of 5 stars5/5The Great Awakening: Defeating the Globalists and Launching the Next Great Renaissance Rating: 4 out of 5 stars4/5Enough Rating: 5 out of 5 stars5/5The January 6th Report Rating: 4 out of 5 stars4/5Government Gangsters: The Deep State, the Truth, and the Battle for Our Democracy Rating: 5 out of 5 stars5/5Profiles in Ignorance: How America's Politicians Got Dumb and Dumber Rating: 4 out of 5 stars4/5Treating People Well: The Extraordinary Power of Civility at Work and in Life Rating: 4 out of 5 stars4/5Get Trump: The Threat to Civil Liberties, Due Process, and Our Constitutional Rule of Law Rating: 5 out of 5 stars5/5American Marxism Rating: 3 out of 5 stars3/5Science of Coercion: Communication Research & Psychological Warfare, 1945–1960 Rating: 4 out of 5 stars4/5
Related podcast episodes
Policy Concepts in 1000 Words: The Advocacy Coalition Framework 0% found this document usefulEp. 368 The Recent Trend of Insurance Denials for CLI Interventions with Dr. Bret Wiechmann 0% found this document useful#340: LDTs & the FDAs Proposed Ruling 0% found this document usefulFrom Capitol Hill to Patient Care: Bridging the Gap 0% found this document usefulRising to the COVID-19 challenge, clinical trials evolve 0% found this document usefulNavigating Risk Management in Medical Devices with Brian Dense 0% found this document usefulMichael Zezas: The Year of the Long-Term Investor 0% found this document useful7investing Explains: How are Medical Devices and Genetic Tests Regulated? 0% found this document useful7investing Explains: How are Medical Devices and Genetic Tests Regulated? 0% found this document usefulESG disclosures: What matters to investors 0% found this document usefulGetting Answers on Vaccine Boosters 0% found this document usefulDr. Aseem Malhotra: Big Pharma Has Had a Net Negative Impact on Society in Recent Decades 0% found this document usefulRecent FDA Enforcement Trends with George Toscano 0% found this document usefulEpisode 38 - Sewage Sludge, The Environmental Disaster You Don’t Know About with Dr. David Lewis 0% found this document useful
Related articles
Industry’s Newest Tactics to Undermine EPA Science Union of Concerned ScientistsArticle
Industry’s Newest Tactics to Undermine EPA Science
Apr 11, 2024
Industry is attempting some new tactics to undermine independent science and science-based decisionmaking at the Environmental Protection Agency (EPA). The EPA previously released their updated scientific integrity policy for public comment, and many
5 min readOn EPA Scientific Integrity, Wall Street Journal is Short of Facts Union of Concerned ScientistsArticle
On EPA Scientific Integrity, Wall Street Journal is Short of Facts
May 26, 2017
An opinion piece in today’s Wall Street Journal misrepresents the facts about an annual meeting on scientific integrity at the EPA and the role of the EPA scientific integrity officer. Here are some details about what that meeting is and the role of
3 min readRoundup: Biden Administration Revamps Procedures for Reviewing Regulations Union of Concerned ScientistsArticle
Roundup: Biden Administration Revamps Procedures for Reviewing Regulations
Jan 26, 2024
Science Network blogger Liz Borkowski provides a roundup of scientific integrity news from the past few months.
5 min readNew Report Underscores the Need to Prevent Political Interference at US Public Health Agencies Union of Concerned ScientistsArticle
New Report Underscores the Need to Prevent Political Interference at US Public Health Agencies
Oct 10, 2023
A new report released by the Government Accountability Office (GAO) provides a roadmap on how best to protect the nation’s public health agencies against political interference in government science. The report was developed in response to the devast
3 min readThe Damage To Science That President-Elect Biden Can Undo With A Stroke Of A Pen Union of Concerned ScientistsArticle
The Damage To Science That President-Elect Biden Can Undo With A Stroke Of A Pen
Nov 10, 2020
3 min readMISSING IN ACTION: Policy Implications of Management Research The European Business ReviewArticle
MISSING IN ACTION: Policy Implications of Management Research
Feb 1, 2023
6 min readHistoric Opportunity to Strengthen Scientific Integrity Policies Union of Concerned ScientistsArticle
Historic Opportunity to Strengthen Scientific Integrity Policies
Apr 20, 2023
Major US federal agencies are now conferring about how best to implement the Biden administration’s historic scientific integrity framework.
3 min readRoundup: Movement on Agency Scientific Integrity Policies Union of Concerned ScientistsArticle
Roundup: Movement on Agency Scientific Integrity Policies
Oct 24, 2023
How is scientific integrity being protected at federal agencies? Liz Borkowski offers the latest roundup.
6 min readFighting Fragmentation in Healthcare: A Modest Proposal Rotman ManagementArticle
Fighting Fragmentation in Healthcare: A Modest Proposal
Jan 1, 2019
10 min readRoundup: Signs of Hope for Scientific Integrity and Public Health Union of Concerned ScientistsArticle
Roundup: Signs of Hope for Scientific Integrity and Public Health
Apr 8, 2021
7 min readFour New (Old) Ways the White House is Trying to Restrict Science for Policymaking Union of Concerned ScientistsArticle
Four New (Old) Ways the White House is Trying to Restrict Science for Policymaking
Apr 25, 2019
5 min readScott Pruitt’s Regulatory Rollback Recipe Union of Concerned ScientistsArticle
Scott Pruitt’s Regulatory Rollback Recipe
Apr 16, 2018
2 min readThe Regulatory State Is Failing Us The AtlanticArticle
The Regulatory State Is Failing Us
May 29, 2020
9 min readOpinion: FDA Is Smashing The Status Quo For Regulatory Science STATArticle
Opinion: FDA Is Smashing The Status Quo For Regulatory Science
Oct 14, 2019
The FDA can enable innovation by being a partner in advancing new approaches to drug development and regulatory science. Its recent reorganization signals a revolutionary shift in regulatory velocity.
5 min readTwo Years Of Attacks On Science Are Putting Public Health And Safety At Risk Union of Concerned ScientistsArticle
Two Years Of Attacks On Science Are Putting Public Health And Safety At Risk
Jan 28, 2019
4 min readRoundup: A New Scientific Integrity Framework and Overstretched EPA Staff Union of Concerned ScientistsArticle
Roundup: A New Scientific Integrity Framework and Overstretched EPA Staff
May 12, 2023
This post is part of a series of quarterly roundups on scientific integrity. In the first quarter of 2023, the Biden administration released a framework to help agencies strengthen their scientific integrity policies; several organizations praised it
4 min readCommentary: Directors Of Top Cancer Centers Shouldn't Take Money From Drug Companies Los Angeles TimesArticle
Commentary: Directors Of Top Cancer Centers Shouldn't Take Money From Drug Companies
Aug 7, 2019
Academic cancer centers are exalted for producing cutting-edge research and providing superior cancer care. Doctors and the public look to them for unbiased evidence on which cancer treatments lead to meaningful improvements in survival and quality o
3 min readNew White House Guidance Protects Federal Scientists and Their Work Union of Concerned ScientistsArticle
New White House Guidance Protects Federal Scientists and Their Work
Jan 12, 2023
The new framework helps protect science-based decisions from undue political interference at all federal agencies.
5 min readOpinion: For Medicine Regulators, Reliance Is A Global Imperative STATArticle
Opinion: For Medicine Regulators, Reliance Is A Global Imperative
Feb 27, 2020
A new report from the U.S. National Academies, "Regulating Medicines in a Globalized World," shows how regulatory authorities can work together and avoid duplication.
4 min readAdvisory Committee Shakeup Targets Independent Science and Scientists Union of Concerned ScientistsArticle
Advisory Committee Shakeup Targets Independent Science and Scientists
May 8, 2017
There is a full-on assault afoot to strip away the independence of science advisory committees at several government agencies.
6 min readRoundup: EPA Releases Several Rules and a Draft Scientific Integrity Policy Union of Concerned ScientistsArticle
Roundup: EPA Releases Several Rules and a Draft Scientific Integrity Policy
Apr 17, 2024
In this latest scientific integrity roundup, a preview of Supreme Court cases that could limit federal agencies' ability to set protective standards.
5 min read5 Ways the Trump Administration Uses Disinformation & Why We Need Oversight Union of Concerned ScientistsArticle
5 Ways the Trump Administration Uses Disinformation & Why We Need Oversight
Feb 25, 2019
3 min readCommentary: Fossil Fuel Money Compromises Climate Research. Here’s How To Fix It Los Angeles TimesArticle
Commentary: Fossil Fuel Money Compromises Climate Research. Here’s How To Fix It
Nov 9, 2023
3 min readHow Lobbying Undercuts Climate Action FuturityArticle
How Lobbying Undercuts Climate Action
May 31, 2019
2 min readFor the First Time Ever, the White House Adopts a Model Scientific Integrity Policy Union of Concerned ScientistsArticle
For the First Time Ever, the White House Adopts a Model Scientific Integrity Policy
Jun 28, 2023
The White House has just released a scientific integrity policy. Find out how it measures up to UCS expectations.
4 min readOpinion: Mending The Broken Social Contract For Pharmaceutical Pricing And Innovation STATArticle
Opinion: Mending The Broken Social Contract For Pharmaceutical Pricing And Innovation
Mar 13, 2020
A new social contract that reduces the dependency of research investments on high prices and industry profits will create additional social benefits for the industry and society.
5 min readWorried for Government Science? So Are We. Union of Concerned ScientistsArticle
Worried for Government Science? So Are We.
Aug 25, 2020
3 min readEPA’s New Scientific Integrity Policy: the Good, the Bad, and the Ugly Union of Concerned ScientistsArticle
EPA’s New Scientific Integrity Policy: the Good, the Bad, and the Ugly
Jan 30, 2024
The Environmental Protection Agency (EPA) recently released its updated scientific integrity policy for public comment. Here are the details and how you can make your voice heard.
5 min readThe Coronavirus Could Help Pharma Reset Its Reputation In Washington STATArticle
The Coronavirus Could Help Pharma Reset Its Reputation In Washington
Mar 3, 2020
4 min readOpinion: Pharma Should Take A Tip From The Chemical Industry To Stem The Outrage Over Drug Pricing STATArticle
Opinion: Pharma Should Take A Tip From The Chemical Industry To Stem The Outrage Over Drug Pricing
May 10, 2018
3 min read
Reviews for Industry Influence in Federal Regulatory Agencies
Rating: 0 out of 5 stars
0 ratings
0 ratings0 reviews